Dr Reddys Laboratories (RDY) Other Accumulated Expenses (2009 - 2026)
Dr Reddys Laboratories' Other Accumulated Expenses came in at $459.73 million for the quarter ended Jun 30, 2026, down 10.1% from $511.52 million a year earlier and down 16.4% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Other Accumulated Expenses (2009 - 2026) Analysis & Trends
As of Mar 31, 2026, Dr Reddys Laboratories' Other Accumulated Expenses was $537 million, up 0.8% from the prior year.
- Other Accumulated Expenses has increased in each of the last seven years, with a five-year compound annual growth rate of 5.2% (years ended Mar 2021 to Mar 2026).
- Going back by year, Other Accumulated Expenses was $533 million in the year ended Mar 31, 2025 (+3.5%), $515 million in the year ended Mar 31, 2024 (+7.3%), $480 million in the year ended Mar 31, 2023 (+7.1%) and $448 million in the year ended Mar 31, 2022 (+7.4%).
- The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly Other Accumulated Expenses since the quarter ended Jun 30, 2024.
- Year-over-year, Other Accumulated Expenses increased in seven of the last eight quarters, with growth averaging 5.4%.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in the quarter ended Jun 30, 2025 (growth of 17.0%), and the weakest in the quarter ended Jun 30, 2026 (a decline of 10.1%).
- Business Quant data shows RDY's Other Accumulated Expenses at $549.79 million (quarter ended Mar 31, 2026), $517.09 million (quarter ended Dec 31, 2025) and $536.15 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Dr Reddys Laboratories | 10.22 Bn | 9.41 Bn | 396.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 459.73 Mn |
| Mar 31, 2026 | 549.79 Mn |
| Dec 31, 2025 | 517.09 Mn |
| Sep 30, 2025 | 536.15 Mn |
| Jun 30, 2025 | 511.52 Mn |
| Mar 31, 2025 | 525.26 Mn |
| Dec 31, 2024 | 497.72 Mn |
| Sep 30, 2024 | 499.27 Mn |
| Jun 30, 2024 | 437.04 Mn |
| Mar 31, 2024 | 516.55 Mn |
| Dec 31, 2023 | 468.01 Mn |
| Sep 30, 2023 | 444.50 Mn |
| Jun 30, 2023 | 433.20 Mn |
| Mar 31, 2023 | 480.17 Mn |
| Dec 31, 2022 | 423.05 Mn |
| Sep 30, 2022 | 417.82 Mn |
| Jun 30, 2022 | 427.89 Mn |
| Mar 31, 2022 | 452.06 Mn |
| Dec 31, 2021 | 417.84 Mn |
| Sep 30, 2021 | 412.31 Mn |
API Access
Dr Reddys Laboratories Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();